AMMJ (American Cannabis Co) Notes Receivable : $0.00 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is American Cannabis Co Notes Receivable?

American Cannabis Co's Notes Receivable for the quarter that ended in Mar. 2024 was $0.00 Mil.

American Cannabis Co Notes Receivable Historical Data

The historical data trend for American Cannabis Co's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Cannabis Co Notes Receivable Chart

American Cannabis Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Notes Receivable

Get a 7-Day Free Trial

American Cannabis Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Notes Receivable	Get a 7-Day Free Trial															-	-	-	-	-

American Cannabis Co Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

American Cannabis Co Notes Receivable Related Terms

Thank you for viewing the detailed overview of American Cannabis Co's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

American Cannabis Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Tobacco Products » American Cannabis Co Inc (OTCPK:AMMJ) » Definitions » Notes Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

1004 Tejon Street, Colorado Springs, CO, USA, 80903

Website

https://www.americancannabisconsulting.com

American Cannabis Co Inc is engaged in the cannabis industry that features end-to-end solutions for businesses operating in the regulated cannabis industry in states and countries where cannabis is regulated and/or has been decriminalized for medical use and/or legalized for recreational use. It provides advisory and consulting services specific to this industry, designs industry-specific products and facilities, and manages a strategic group partnership that offers both exclusive and non-exclusive customer products commonly used in the industry. It is a licensed operator of two medical cannabis dispensaries and a cannabis cultivation facility in Colorado Springs, CO.

Executives

Tyler A Schloesser	officer: Chief Operations Officer	9874 WEST LA SALLE PLACE, LAKEWOOD CO 80227
Ellis Lamar Smith	director, 10 percent owner, officer: Cheif Development Officer	2590 WALNUT ST, DENVER CO 80205
Hollister Corey James Ariel	director, 10 percent owner, officer: Chief Executive Officer	5316 RUSTIC AVE, FIRESTONE CO 80504
David Michael Godfrey	officer: Principal Accounting Officer	5690 LOGAN STREET, DENVER CO 80237
Jon Workman	officer: Vice President	2600 RAY DEAN ROAD, TUCKER AR 72168
Michael Schwanbeck	officer: Chief Financial Officer	555 E. 19TH AVENUE, #2421, DENVER CO 80203
Tad M Mailander	director	4811 49TH STREET, SAN DIEGO CA 92115
Terry Lynn Buffalo	director, officer: CEO	3063 BRIGHTON BLVD, #918, DENVER CO 80216
Jesus Quintero	officer: Former CFO	16860 SOUTHWEST 1ST STREET, PEMBROKE PINES FL 33027
Michael A Novielli	director, 10 percent owner	100 MILL PLAIN ROAD, 3RD FLOOR, DANBURY CT 06811
Anthony J Baroud	director, 10 percent owner, officer: Chief Technology Officer	211 EAST CIRCLE AVE, PROSPECT HEIGHTS IL 60070
Themistocles Psomiadis	director, officer: Chief Executive Officer	1420 MIDTOWN AVE, APT 407, MOUNT PLEASANT SC 29464
Villas Boas Andrea Bezerra Arruda	10 percent owner	ALAMEDA UAPIXANA, 278, SAO PAULO D5 04085-030
Douglas Leighton	director	312 STUART ST, BOSTON MA 02116
Donald Brucker	director, 10 percent owner, officer: VP Research & Development	110 WEST C STREET, SUITE 1300, SAN DIEGO CA 92101